UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Pinnacle Wealth Planning Services Inc.

Pinnacle Wealth Planning Services Inc. reduced its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 31.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,135 shares of the healthcare conglomerate's stock after selling 1,932 shares during the quarter. Pinnacle Wealth Planning Services Inc.'s holdings in UnitedHealth Group were worth $2,091,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. NewSquare Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the 4th quarter valued at $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group during the 4th quarter worth about $30,000. Finally, AlphaMark Advisors LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $30,000. Institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. TD Cowen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price on the stock. in a research note on Monday, May 19th. TD Securities restated a "hold" rating and issued a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. KeyCorp lowered their price target on UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Erste Group Bank lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. Finally, Royal Bank of Canada decreased their target price on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $441.87.

UnitedHealth Group Trading Down 0.4%

Shares of UNH traded down $1.15 during mid-day trading on Thursday, reaching $296.97. 10,351,888 shares of the company were exchanged, compared to its average volume of 6,724,002. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The business has a 50 day simple moving average of $439.50 and a two-hundred day simple moving average of $498.65. The stock has a market capitalization of $269.39 billion, a PE ratio of 19.14, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the previous year, the business earned $6.91 earnings per share. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CEO Stephen J. Hemsley acquired 86,700 shares of the business's stock in a transaction on Friday, May 16th. The stock was acquired at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the acquisition, the chief executive officer now directly owns 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Kristen Gil bought 3,700 shares of the company's stock in a transaction that occurred on Thursday, May 15th. The shares were bought at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the transaction, the director now owns 3,818 shares of the company's stock, valued at $1,035,327.06. The trade was a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 109,408 shares of company stock worth $31,607,768 in the last three months. Insiders own 0.33% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.